Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score
…, T Yang, P Zhao, G Chen, G Cheng… - Clinical Infectious …, 2020 - academic.oup.com
Background We aimed to clarify high-risk factors for coronavirus disease 2019 (COVID-19)
with multivariate analysis and establish a predictive model of disease progression to help …
with multivariate analysis and establish a predictive model of disease progression to help …
[HTML][HTML] Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
Background The pathogenesis of chronic idiopathic thrombocytopenic purpura (ITP) involves
antibody-mediated platelet destruction and reduced platelet production. Stimulation of …
antibody-mediated platelet destruction and reduced platelet production. Stimulation of …
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
D Ji, E Qin, J Xu, D Zhang, G Cheng… - Journal of …, 2020 - journal-of-hepatology.eu
Methods From January 20 through February 17, 2020, consecutive patients admitted to 2
designated COVID-19 Hospitals in China with confirmed COVID-19 and information on NAFLD …
designated COVID-19 Hospitals in China with confirmed COVID-19 and information on NAFLD …
Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis
Objectives To evaluate the haematological findings of patients with severe acute respiratory
syndrome (SARS). Design Analysis of the demographic, clinical, and laboratory …
syndrome (SARS). Design Analysis of the demographic, clinical, and laboratory …
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
G Cheng, MN Saleh, C Marcher, S Vasey, B Mayer… - The Lancet, 2011 - thelancet.com
Background Eltrombopag is an oral thrombopoietin receptor agonist for the treatment of
thrombocytopenia. We aimed to compare the response to once daily eltrombopag versus …
thrombocytopenia. We aimed to compare the response to once daily eltrombopag versus …
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo …
Background Eltrombopag is an oral, non-peptide, thrombopoietin-receptor agonist that
stimulates thrombopoiesis, leading to increased platelet production. This study assessed the …
stimulates thrombopoiesis, leading to increased platelet production. This study assessed the …
[HTML][HTML] Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone
Y Cheng, RSM Wong, YOY Soo, CH Chui… - … England Journal of …, 2003 - Mass Medical Soc
Background The role of high-dose dexamethasone in the treatment of immune
thrombocytopenic purpura in adults is controversial. We assessed the effectiveness of high-dose …
thrombocytopenic purpura in adults is controversial. We assessed the effectiveness of high-dose …
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
MN Saleh, JB Bussel, G Cheng, O Meyer… - Blood, The Journal …, 2013 - ashpublications.org
Patients with chronic immune thrombocytopenia may have bleeding resulting from low platelet
counts. Eltrombopag increases and maintains hemostatic platelet counts; however, to date…
counts. Eltrombopag increases and maintains hemostatic platelet counts; however, to date…
Provision of phenotype-matched blood units: no need for pre-transfusion antibody screening
BACKGROUND AND OBJECTIVES: The Hong Kong government is planning to introduce an
electronic smart identity card for all seven million citizens in 2003. If the smart card contains …
electronic smart identity card for all seven million citizens in 2003. If the smart card contains …
ABO blood group and susceptibility to severe acute respiratory syndrome
Methods Methods The first major SARS outbreak in Hong Kong occurred in March 2003.
The index case was a patient who was admitted to Prince of Wales Hospital, a 1000-bed …
The index case was a patient who was admitted to Prince of Wales Hospital, a 1000-bed …